Literature DB >> 4748385

Urinary hydroxyproline excretion in early and advanced breast cancer-a sequential study.

A Cuschieri.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4748385     DOI: 10.1002/bjs.1800601012

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


× No keyword cloud information.
  10 in total

1.  Urinary hydroxyproline in the management of breast cancer.

Authors:  A Cuschieri
Journal:  World J Surg       Date:  1977-05       Impact factor: 3.352

2.  The role of skeletal scintigraphy in detection of metastatic breast cancer.

Authors:  C S Galasko
Journal:  World J Surg       Date:  1977-05       Impact factor: 3.352

Review 3.  Mechanisms for the development of bone metastases and hypercalcaemia in patients with breast cancer.

Authors:  T J Powles
Journal:  Proc R Soc Med       Date:  1977-03

4.  The early detection of recurrent and metastatic oncological disease.

Authors:  C S Galasko
Journal:  Proc R Soc Med       Date:  1974-09

5.  Biological considerations in the treatment of early carcinoma of the breast and their role in the selection of therapy.

Authors:  M Baum
Journal:  Ann R Coll Surg Engl       Date:  1980-01       Impact factor: 1.891

6.  Hydroxyproline excretion in patients with breast cancer and response to treatment.

Authors:  T J Powles; C L Leese; P K Bondy
Journal:  Br Med J       Date:  1975-04-26

7.  Study of hydroxyproline excretion in patients with prostatic cancer.

Authors:  I Romics; I Budavári; L Kisbenedek; F Balogh
Journal:  Int Urol Nephrol       Date:  1981       Impact factor: 2.370

8.  Problems associated with the detection of skeletal metastases.

Authors:  C S Galasko
Journal:  J R Soc Med       Date:  1978-01       Impact factor: 18.000

9.  The role of tumour markers in predicting skeletal metastases in breast cancer patients with equivocal bone scintigraphy.

Authors:  A Nicolini; P Ferrari; A Sagripanti; A Carpi
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

10.  Three-centre study on urinary hydroxyproline excretion in cancer of the breast.

Authors:  A Cuschieri; R Jarvie; W H Taylor; E Cant; C M Furnival; L H Blumgart
Journal:  Br J Cancer       Date:  1978-06       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.